OraSure Technologies(OSUR) - 2024 Q1 - Quarterly Results

Q1 GAAP EPS of $(0.05); Q1 Non-GAAP EPS of$0.04 Restructuring initiatives expected to result in $15 million of annualized expense reductions once fully implemented and position OraSure to achieve cash flow breakeven for core business by end of 2024 EXHIBIT 99.1 Investor Contact: Media Contact: Jason Plagman Amy Koch investorinfo@orasure.com media@orasure.com VP, Investor Relations Director, Corporate Communications OraSure Reports Q1 '24 Revenue of$54.1 Million Delivered initial orders for Syphilis Health ...